Life Extension Targets Blood Glucose Control
The company’s new GlycemicPro Transglucosidase supplement limits the release of starch-origin sugars.
Life Extension has launched a new dietary supplement that protects against blood glucose surges by limiting the release of carbohydrates from starchy foods like breads and pasta. The key ingredient in GlycemicPro Transglucosidase is the enzyme Transglucosidase, which is derived from Asperegillus niger, and has been the subject of a number of published studies.
The product claims to convert dietary starch into a “beneficial indigestible prebiotic fiber,” effectively lowering the level of rapidly digested starch in carbohydrate-rich foods by 31%. It also claims to help maintain healthy cholesterol and insulin levels.
One capsule of GlycemicPro Transglucosidase taken with a starchy meal delivers 450,000 activity units of transglucosidase. The product, which is non-GMO and vegan-friendly, retails for $54 for a 60 count bottle.
Sirio Pharma launches line of ready-to-market organic gummies and softgels called PureOrganix
August 26th 2024The new line is made up of three gummies and one softgel that are formulated to meet stringent EU-Organic certification criteria, and target women’s health, metabolic health, and heart health.
Recent review states that pentadecanoic acid may support cellular stability for better longevity
June 25th 2024According to the paper’s author, Stephanie Venn-Watson, DVM, MPH, deficiency in pentadecanoic acid of ≤0.2% total circulating fatty acids increases the risk of ferroptosis, which a type of cell death cause by the peroxidation of fragile fatty acids in cell membranes that combines with iron thus increasing reactive oxygen species, and disabling mitochondria.
